{
  "(0, 0)": "cancer immunotherapy",
  "(1, 0)": "antibody",
  "(1, 1)": "brand name",
  "(1, 2)": "approval date",
  "(1, 3)": "type",
  "(1, 4)": "target",
  "(2, 0)": "alemtuzumab",
  "(2, 1)": "campath",
  "(2, 2)": "2001",
  "(2, 3)": "humanized",
  "(2, 4)": "cd52",
  "(3, 0)": "bevacizumab",
  "(3, 1)": "avastin",
  "(3, 2)": "2004",
  "(3, 3)": "humanized",
  "(3, 4)": "vascular endothelial growth factor",
  "(4, 0)": "brentuximab vedotin",
  "(4, 1)": "adcetris",
  "(4, 2)": "2011",
  "(4, 3)": "chimeric",
  "(4, 4)": "cd30",
  "(5, 0)": "cetuximab",
  "(5, 1)": "erbitux",
  "(5, 2)": "2004",
  "(5, 3)": "chimeric",
  "(5, 4)": "epidermal growth factor receptor",
  "(6, 0)": "gemtuzumab ozogamicin",
  "(6, 1)": "mylotarg",
  "(6, 2)": "2000",
  "(6, 3)": "humanized",
  "(6, 4)": "cd33",
  "(7, 0)": "ibritumomab tiuxetan",
  "(7, 1)": "zevalin",
  "(7, 2)": "2002",
  "(7, 3)": "murine",
  "(7, 4)": "cd20",
  "(8, 0)": "panitumumab",
  "(8, 1)": "vectibix",
  "(8, 2)": "2006",
  "(8, 3)": "human",
  "(8, 4)": "epidermal growth factor receptor",
  "(9, 0)": "rituximab",
  "(9, 1)": "rituxan , mabthera",
  "(9, 2)": "1997",
  "(9, 3)": "chimeric",
  "(9, 4)": "cd20",
  "(10, 0)": "trastuzumab",
  "(10, 1)": "herceptin",
  "(10, 2)": "1998",
  "(10, 3)": "humanized",
  "(10, 4)": "erbb2"
}